The Anticancer Drugs

Produk Detail:
  • Author : William B. Pratt
  • Publisher : Oxford University Press, USA
  • Pages : 366 pages
  • ISBN : 9780195067392
  • Rating : 2/5 from 1 reviews
CLICK HERE TO GET THIS BOOK >>>The Anticancer Drugs

Download or Read online The Anticancer Drugs full in PDF, ePub and kindle. this book written by William B. Pratt and published by Oxford University Press, USA which was released on 25 September 1994 with total page 366 pages. We cannot guarantee that The Anticancer Drugs book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. This is an up-to-date review of the pharmacology, mechanisms of action, development of resistance, and toxicity of cancer chemotherapeutic agents. A rationale for their clinical use, based on cancer cell biology, is given for each class of drugs.

The Anticancer Drugs

The Anticancer Drugs
  • Author : William B. Pratt
  • Publisher : Oxford University Press, USA
  • Release : 25 September 1994
GET THIS BOOK The Anticancer Drugs

This is an up-to-date review of the pharmacology, mechanisms of action, development of resistance, and toxicity of cancer chemotherapeutic agents. A rationale for their clinical use, based on cancer cell biology, is given for each class of drugs.

Anticancer Molecules

Anticancer Molecules
  • Author : Hiroshi Maruta
  • Publisher : Unknown
  • Release : 25 September 1999
GET THIS BOOK Anticancer Molecules

This volume discusses the value of research on tumor suppressor genes and the structure-function relationship of the corresponding proteins. The applicability of these non-peptide molecules to anti-cancer drugs is also taken up; and by focusing on contemporary research issues in the field, the book aims to promote understanding and cooperation between industrial and academic researchers.

Heterocyclic Anticancer Agents

Heterocyclic Anticancer Agents
  • Author : Bimal Krishna Banik,Bubun Banerjee
  • Publisher : Walter de Gruyter GmbH & Co KG
  • Release : 21 June 2022
GET THIS BOOK Heterocyclic Anticancer Agents

Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies.

Anticancer Genes

Anticancer Genes
  • Author : Stefan Grimm
  • Publisher : Springer
  • Release : 08 July 2014
GET THIS BOOK Anticancer Genes

This book discusses the emergence of a new class of genes with a specific anticancer activity. These genes, recently defined as “Anticancer Genes”, are reviewed in individual chapters on their mode of action, the specific cell death signals they induce, and the status of attempts to translate them into clinical application. Anticancer Genes provides an overview of this nascent field, its genesis, current state, and prospect. It discusses how Anticancer Genes might lead to the identification of a repertoire of

Key Heterocyclic Cores for Smart Anticancer Drug Design Part I

Key Heterocyclic Cores for Smart Anticancer Drug   Design Part I
  • Author : Rajesh Kumar Singh
  • Publisher : Bentham Science Publishers
  • Release : 05 July 2022
GET THIS BOOK Key Heterocyclic Cores for Smart Anticancer Drug Design Part I

This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in pharmaceutical chemistry and are written to give a general overview of

Advances in Anticancer Agents in Medicinal Chemistry

Advances in Anticancer Agents in Medicinal Chemistry
  • Author : Michelle Prudhomme
  • Publisher : Bentham Science Publishers
  • Release : 14 June 2013
GET THIS BOOK Advances in Anticancer Agents in Medicinal Chemistry

Advances in Anticancer Agents in Medicinal Chemistry is an exciting eBook series comprising a selection of updated articles previously published in the peer-reviewed journal Anti-Cancer Agents in Medicinal Chemistry. The second Volume of this eBook series gathers updated reviews on several classes of molecules exhibiting anticarcinogenic potential as well as some important targets for the development of novel anticancer drugs.

Evidence based Anticancer Materia Medica

Evidence based Anticancer Materia Medica
  • Author : William C.S. Cho
  • Publisher : Springer Science & Business Media
  • Release : 29 March 2011
GET THIS BOOK Evidence based Anticancer Materia Medica

Cancer is one of the leading killers in the world and the incidence is increasing, but most cancer patients and cancer survivors suffer much from the disease and its conventional treatments’ side effects. In the past, clinical data showed that some complementary and alternative medicine (CAM) possessed anticancer abilities, but some clinicians and scientists have queried about the scientific validity of CAM due to the lack of scientific evidence. There is great demand in the knowledge gap to explore the

Metallo Drugs Development and Action of Anticancer Agents

Metallo Drugs  Development and Action of Anticancer Agents
  • Author : Astrid Sigel,Helmut Sigel,Eva Freisinger,Roland K.O. Sigel
  • Publisher : Walter de Gruyter GmbH & Co KG
  • Release : 05 February 2018
GET THIS BOOK Metallo Drugs Development and Action of Anticancer Agents

Volume 18, entitled Metallo-Drugs: Development and Action of Anticancer Agents of the series Metal Ions in Life Sciences centers on biological, medicinal inorganic chemistry. The serendipitous discovery of the antitumor activity of cis-diamminodichloroplatinum(II) (cisplatin) by Barnett Rosenberg in the 1960s is a landmark in metallodrug-based chemotherapy. The success of cisplatin in the clinic, followed by oxaliplatin and carboplatin, along with their drawbacks relating mainly to resistance development and severe toxicity, initiated research on polynuclear platinum complexes and on Pt(IV)

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
  • Author : Michelle A. Rudek,Cindy H. Chau,William D. Figg,Howard L. McLeod
  • Publisher : Springer Science & Business Media
  • Release : 10 January 2014
GET THIS BOOK Handbook of Anticancer Pharmacokinetics and Pharmacodynamics

There are many steps on the road from discovery of an anticancer drug to securing its final approval by the Food and Drug Administration. In this thoroughly updated and expanded second edition of the Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, leading investigators synthesize an invaluable overview of the experimental and clinical processes of anticancer drug development, creating a single indispensable reference that covers all the steps from the identification of cancer-specific molecular targets to screening techniques and the development and

Anticancer Agents from Natural Products

Anticancer Agents from Natural Products
  • Author : Gordon M. Cragg,David G. I. Kingston,David J. Newman
  • Publisher : CRC Press
  • Release : 13 June 2005
GET THIS BOOK Anticancer Agents from Natural Products

Plants, marine organisms, and microorganisms have evolved complex chemical defense and signaling systems that are designed to protect them from predators and provide other biological benefits. These organisms thus produce substances containing novel chemotypes that may have beneficial effects for humans. As collection methods improve and new screen

Frontiers in Anti Cancer Drug Discovery

Frontiers in Anti Cancer Drug Discovery
  • Author : Atta-ur-Rahman,M. Iqbal Choudhary
  • Publisher : Bentham Science Publishers
  • Release : 03 November 2015
GET THIS BOOK Frontiers in Anti Cancer Drug Discovery

Frontiers in Anti-Cancer Drug Discovery is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each

Topics in Anti Cancer Research Volume 10

Topics in Anti Cancer Research  Volume 10
  • Author : Atta-ur-Rahman
  • Publisher : Bentham Science Publishers
  • Release : 13 December 2021
GET THIS BOOK Topics in Anti Cancer Research Volume 10

Topics in Anti-Cancer Research covers new developments in the field of cancer diagnosis and drug therapy. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. The series also covers information on the current understanding of the pathology and molecular biology of specific neoplasms. The diversity of research topics published in this book series give broad and valuable perspectives for cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment

Topics in Anti Cancer Research Volume 8

Topics in Anti Cancer Research  Volume 8
  • Author : Atta-ur-Rahman,Khurshid Zaman
  • Publisher : Bentham Science Publishers
  • Release : 31 December 2019
GET THIS BOOK Topics in Anti Cancer Research Volume 8

Topics in Anti-Cancer Research covers new developments in the field of cancer. Novel drugs as anticancer agents include natural and synthetic phenazines and other anti-cancer compounds. It also encompasses the role of estrogen as endocrine disruptors and strategies targeting cancer stem cells for the treatment of different types of cancers, including myeloma and renal cell cancer. The diversity of researches and topics published in this eBook Series will be valuable to cancer researchers, clinicians, and cancer professionals aiming to develop